publication date: Mar. 29, 2019
Drugs & Targets FDA advances policy changes to modernize mammography services
FDA announced steps to modernize breast cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care.
The proposed rule is posted here.
For the first time in more than 20 years of regulating mammography facilities, the agency is proposing amendments to key regulations that would help improve the quality of mammography services for millions of Americans.
These actions would expand the information mammography facilities must provide to patients and health care professionals, allowing for more informed medical decision-making. It would also modernize mammography quality standards and better position the FDA to enforce regulations that apply to the safety and quality of mammography services.
FDA’s proposal would amend regulations issued under the Mammography Quality Standards Act of 1992, which Congress passed to ensure quality mammography for early breast cancer detection. The MQSA authorizes FDA oversight over mammography facilities, including their accreditation, certification, annual inspections and enforcement of standards to help ensure mammography facilities provide quality care.
Among the proposed amendments to improve communication and medical decision making is the addition of breast density information to the mammography lay summary letter provided to patients and to the medical report provided to … Continue reading FDA advances policy changes to modernize mammography services
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.